|
|
nombre  pulsa para comparar los precios |
| 4-WayNasal | | Ability, Alpha Keri, Ammens | Ban, Bristol Myers  , Bristol Myers Squibb, Bufferin, BuSpar | | Cardiolite, Comtrex, Coumadin | | DuPont Pharmaceutical | | Elisor, Excedrin | | Fisherman’s Friend, Fostex | | Glucophage | | Herbal Essences | | Keri, Kosan Biosciences | | Medarex, Moisturel | | NoDoz, Nuprin | | Platinol, PreSun | | Saugella, Sea Breeze, Squibb, Sustiva | | Taxol, Tempra, Therapeutic Mineral Ice | | Vagistat-1 |
Compremos local, ética y al mejor precio sobre Ethishop  |
|
| |
|
año | actividad fuente |
| 2006 | Bristol Myers Squibb es el decimotercer grupo farmacéutico mundial. | Les Echos |
|
| país | dirección & contacto : tipo de producción incentivo fuente |
 Bermuda | Bristol-Myers Squibb Service Ltd : |
| Bermuda | Grove Insurance Company Ltd : |
 Brasil | : Centro Nuovo Modello di Sviluppo |
 Colombia | : Centro Nuovo Modello di Sviluppo |
 Costa Rica | Bristol-Myers Squibb de Costa Rica, S.A : |
 Dominica | Bristol-Myers Industrial inc. : |
 Guam | Bristol-Myers Overseas Corporation : |
 Irán | : Centro Nuovo Modello di Sviluppo |
 Irlanda | Bristol-Myers Squibb Pharmaceuticals Ltd : |
 Líbano | Bristol-Myers Middle East S.A.L : |
 Mexico | DISTRITO FEDERAL ALVARO OBREGON REVOLUCION 1267 TLACOPAC & 5 2274800 : Sistema de Informacion de la Industria Maquiladora |
| Mexico | DISTRITO FEDERAL AZCAPOTZALCO PONIENTE 150 764 INDUSTRIAL VALLEJO & 7295400 : Sistema de Informacion de la Industria Maquiladora |
 Pakistán | Bristol-Myers Pakistan (Pvt.) : |
 Panamá | Squibb Middle East S.A : |
| Panamá | Bristol Pharmaceutical Information Center, S.A : |
| Panamá | Bristol Laboratories Products, Inc. : |
 Perú | : Centro Nuovo Modello di Sviluppo |
 Singapur | Bristol-Myers Squibb (Singapore) Pte. Ltd : |
 Suiza | Bristol-Myers Squibb (MEA) S.A : |
 Turquía | : Centro Nuovo Modello di Sviluppo |
|
| año nombre | foto posición; remuneración fuente |
| 2002Dolan, Peter |  Presidente; salario: 1,15 milliones US$; L'Expansion |
| 1998Heimbold, Charles | Presidente; salario: 3,19 milliones US$; stock-options: 30,37 milliones US$;
|
|
| año | empleados <> | impacto social : país fuente |
| 2009 | -123 | Cierre/Quiebra: BMS cierra su fábrica d' Epernon (Eure-et-Loir) debido a capacidades excesivas de fabricación de medicamentos.: Francia | Les Echos |
| 2009 | -160 | Cierre/Quiebra: Bristol Myers Squibb cierra su fábrica de Meymac en Correze.: Francia | Capital |
| 2007 | -4300 | Reestructuración interna: Bristol Myers Squibb elimina el 10% de su fuerza de trabajo global.: | Reuters |
| 2007 | -4300 | Cierre/Quiebra: Bristol Myers Squibb suprimirá un 10% de su personal de aquí a 2010 y cerrará la mitad de sus fábricas, con el fin de generar ahorros de 1.5 mil millones de dólares. Bristol Myers Squibb también anunció previsiones de crecimiento de resultados del 19% en 2008.: | Reuters |
| 2005 | -41 | Cierre/Quiebra: Mise en vente de son centre de recherche et développement de Saint-Nazaire dans le cadre d'un regroupement de sa recherche. Si aucun repreneur ne se manifeste, cette unité sera fermée.  traducir : | Les Echos |
|
| año | empleados <> | impacto social : país fuente |
|
| año | país : consecuencias fuente |
| 2005 | marca: Ability : Older patients with dementia who are given antipsychotic medicines are far more likely to die prematurely than those given placebos. Most died of heart-related problems like heart failure or infections like pneumonia (FDA) traducir | New York Times |
| | Estados Unidos : Implantes en siliconas cancerígenos | Corporate Reporter Card |
|
| año | país : consecuencias fuente |
|
| año | delincuencia financiera | ventas | resultado | | recompra | fuente |
| 2007 |
| 19,3 | 2,2 | | | mil milliones US$ | Les Echos |
| 2005 |
Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said. traducir |
| | | | | | Bloomberg |
| 2005 |
Agreed to pay $300 million in a deal to defer federal prosecution of a conspiracy charge stemming from an accounting scandal. Frederick Schiff, Bristol-Myers former chief financial officer, and Richard Lane, former executive vice president and president of the worldwide medicines group, were indicted on charges of conspiracy and securities fraud. traducir |
| | | | | | AP |
| 2005 |
Has paid about $155,000 to New Mexico as the state's share in the settlement of an antitrust lawsuit; aaccused of overcharging health care services for the cancer-fighting drug Taxol and Children's Motrin traducir |
| | | | | | AP |
| 2004 |
| | 2,4 | | | mil milliones US$ | Les Echos |
| 2004 |
Overstated profits from 1999 to 2002 by 700 millions US$ traducir |
| | | | | | Chicago Tribune |
| 2004 |
Agreed to pay $150 million to settle U.S. Securities and Exchange Commission allegations that it inflated sales by misusing discounts and incentives to drug wholesalers. traducir |
| | | | | | Bloomberg |
| 2003 |
| 20,67 | 2,95 | | | mil milliones US$ | Les Echos |
| 2003 |
Will pay about $670 million to settle allegations that it unlawfully delayed competition for its BuSpar anti-anxiety medication and Taxol cancer therapy. traducir |
| | | | | | Bloomberg |
| 2002 |
| 18,12 | 2,07 | | | mil milliones US$ | |
| 2002 |
SEC probe of sales practices: by offering incentives to wholesalers, BMS may have boosted revenue by as much as $1 billion. traducir |
| | | | | | CNN |
| 2001 |
| 19,42 | 5,25 | | | mil milliones US$ | |
| 2000 |
| 18,22 | 4,71 | | | mil milliones US$ | |
| 1999 |
| 20,22 | 4,17 | | | mil milliones US$ | |
| 1999 |
| | | | 2 | mil milliones US$ | SmartMoney |
| 1998 |
| 18,28 | 3,14 | | | mil milliones US$ | |
|
| año | delincuencia financiera | ventas | resultado | activo | recompra | fuente |
|
| año | objectivo : intermediario/lobby : institución fuente |
| 2001 | : USCIB (US Council For International Business) : : US Government traducir | USCIB |
| 2000 | : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate traducir | Washington Post |
| 2000 | : Business Roundtable : : US government, senate, congress traducir | Center for Responsive Politics |
| 2000 | : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission traducir | EFPIA |
| 2000 | : American Chamber of Commerce's EU Committee : : European Commission traducir | Corporate Europe Observatory |
| 1999 | : Intellectual Property Committee : : WTO traducir | Corporate Europe Observatory |
| 1999 | : ICC (International Chamber of Commerce) : : WTO, GATS traducir | Corporate Europe Observatory |
| 1998 | : Contribution to Candidate's Political Action Committee : importe: 212 mil US$ : US President, Congress, Senate traducir | Center for Responsive Politics |
| 1997 | : Direct donation : importe: 3780 mil US$ : US President, Congress, Senate traducir | Center for Responsive Politics |
| 1997 | : Direct donation : importe: 631 mil US$ : US President, Congress, Senate traducir | Center for Responsive Politics |
|
| año | objectivo : intermediario/lobby : institución fuente |
|
| año | donador | país | importe | fuente |
| 1998 | Etat | Francia | 1 milliones Eu€ | Les Echos |
|
| año | donador | país | importe | fuente |
|
| año | práctica dudosa : imagen fuente |
| 2004 | Colaboración cuestionable: valor: Humanitaire; | AFP |
| 2001 | presupuesto pub: 485 milliones US$; | Advertising Age |
| 2000 | Desinformación: relaciones publicas: K | PR Watch |
| 2000 | presupuesto pub: 424 milliones US$; | Advertising Age |
|
|
|
&sa=OK&client=pub-2642534665785160&forid=1&channel=7573201717&ie=ISO-8859-1&oe=ISO-8859-1&flav=0002&sig=NuXwWEvBGZspbgPc&cof=GALT%3A%23CEA7FF%3BGL%3A1%3BDIV%3A%234A4A4A%3BVLC%3AFF6600%3BAH%3Acenter%3BBGC%3A4A4A4A%3BLBGC%3A4A4A4A%3BALC%3AFFB42D%3BLC%3AFFB42D%3BT%3AFFFFFF%3BGFNT%3AE8DBEF%3BGIMP%3ACEA7FF%3BLH%3A26%3BLW%3A304%3BL%3Ahttp%3A%2F%2Fwww.transnationale.org%2Fimages%2Ftrans2.gif%3BS%3Ahttp%3A%2F%2Fwww.transnationale.org%3BFORID%3A11&hl=es){kind=link}
&sa=OK&client=pub-2642534665785160&forid=1&channel=7573201717&ie=ISO-8859-1&oe=ISO-8859-1&flav=0002&sig=NuXwWEvBGZspbgPc&cof=GALT%3A%23CEA7FF%3BGL%3A1%3BDIV%3A%234A4A4A%3BVLC%3AFF6600%3BAH%3Acenter%3BBGC%3A4A4A4A%3BLBGC%3A4A4A4A%3BALC%3AFFB42D%3BLC%3AFFB42D%3BT%3AFFFFFF%3BGFNT%3AE8DBEF%3BGIMP%3ACEA7FF%3BLH%3A26%3BLW%3A304%3BL%3Ahttp%3A%2F%2Fwww.transnationale.org%2Fimages%2Ftrans2.gif%3BS%3Ahttp%3A%2F%2Fwww.transnationale.org%3BFORID%3A11&hl=es){kind=link}
